These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20268353)

  • 21. [Treatment of severe alcoholic cirrhosis with lyophilized liver extract].
    PERON N
    Gaz Med Fr; 1959 Jun; 66(11):1007-9. PubMed ID: 13664036
    [No Abstract]   [Full Text] [Related]  

  • 22. [The administration of non-purified liver extracts in liver cirrhosis].
    SCHOUTEN J
    Ned Tijdschr Geneeskd; 1953 Apr; 97(16):998-1003. PubMed ID: 13072678
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the therapy of chronic liver diseases with raw liver extract].
    KRENTZ K
    Gastroenterologia; 1960; 93():300-22. PubMed ID: 14411938
    [No Abstract]   [Full Text] [Related]  

  • 24. [Bromsulphalein clearance and blood supply of cirrhotic liver during treatment with total liver extract].
    HOFER R; NEUMAYR A; PARZER O; VETTER H
    Wien Z Inn Med; 1955 Jun; 36(6):237-42. PubMed ID: 13257226
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of pancreatic extract on intestinal iron absorption in liver cirrhosis.
    Brodanová M; Hoenig V; Brodan V; Kuhn E
    Acta Hepatosplenol; 1968; 15(3):141-6. PubMed ID: 5679781
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapeutic action of an enzymatic liver extract in hepatic pathology].
    GAJDOS D
    Gaz Med Fr; 1962 Feb; 69():499-505. PubMed ID: 13896275
    [No Abstract]   [Full Text] [Related]  

  • 27. [CLINICAL EXPERIMENTATION WITH AN INJECTABLE EXTRACT OF LIVER].
    WAREMBOURG H; LEKIEFFRE J
    Lille Med; 1965 Mar; 10():331-5. PubMed ID: 14317083
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of chronic hepatitis and biliary cirrhosis with liver extracts].
    KALK H; WILDHIRT E
    Helv Med Acta; 1952 Oct; 19(4-5):397-402. PubMed ID: 13021788
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of a water soluble antitoxic liver extract in pre and postoperative patients with liver cirrhosis].
    La Gamba F; Manella Neto J; Puglia CA; Thomé J; Chaib SA
    Hospital (Rio J); 1969 Oct; 76(4):1455-70. PubMed ID: 5308124
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of liver extracts and vitamin B12 on experimentally produced liver fibrosis with macrocytosis compared with the effect of a spleen extract.
    PLUM CM
    Arch Int Pharmacodyn Ther; 1956 Feb; 105(1-2):49-67. PubMed ID: 13314720
    [No Abstract]   [Full Text] [Related]  

  • 31. [Trial therapy of various liver diseases with intravenous administration of liver extracts with vitamins and lipotropic substances].
    PACE O
    Minerva Med; 1956 Feb; 47(14):458-60. PubMed ID: 13309035
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of the new treatments of alcoholic cirrhosis, particularly intravenous plasma, on the evolution of ascites].
    LEVRAT M; BRETTE R; RICHARD M; TOLOT F; UGNAT
    Arch Mal Appar Dig Mal Nutr; 1952 Dec; 41(12):1173-81. PubMed ID: 13041361
    [No Abstract]   [Full Text] [Related]  

  • 33. [Conjoined study of arterial and venous blood ammonia in cirrhosis. II. Significance of the ammoniemia induced by the intravenous administration of ammonium chloride in cirrhosis].
    STAHL J; BOCKEL R; IMLER M
    Rev Fr Etud Clin Biol; 1959 Dec; 4():1002-6. PubMed ID: 13833628
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapy of chronic hepatitis and liver cirrhosis with liver extracts].
    KALK H; WILDHIRT E
    Dtsch Med Wochenschr; 1952 Nov; 77(45):1390-3. PubMed ID: 12988839
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacokinetics of lidocaine after intravenous and oral administration in patients with liver cirrhosis].
    Fuchshofen M; Zilly W; Epping J; Richter E
    Verh Dtsch Ges Inn Med; 1978; (84):1110-2. PubMed ID: 741898
    [No Abstract]   [Full Text] [Related]  

  • 36. [Liver hydrolysates in the treatment parenchymal hepatic diseases with special reference to liver cirrhosis].
    WEITHALER K
    Wien Klin Wochenschr; 1956 Feb; 68(5):83-6. PubMed ID: 13312268
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PROLONGED HYPOGLYCEMIA IN RESPONSE TO INTRAVENOUS TOLBUTAMIDE IN A PATIENT WITH LAENNEC'S CIRRHOSIS AND SEVERE MALNUTRITION.
    COHN HJ; PERLMUTTER M; SILVERSTEIN JN; NUMEROFF M
    J Clin Endocrinol Metab; 1964 Jan; 24():28-34. PubMed ID: 14112241
    [No Abstract]   [Full Text] [Related]  

  • 39. Tolerance to intravenously administered protein hydrolysate in severe human liver cirrhosis.
    LEWIS JH; TAYLOR FH; DAVIDSON CS
    Am J Med Sci; 1947 Dec; 214(6):656-61. PubMed ID: 20272373
    [No Abstract]   [Full Text] [Related]  

  • 40. [CLINICAL OBSERVATIONS ON THE THERAPEUTIC EFFECTIVENESS OF AN ASSOCIATION OF ANTITOXIC HEPATIC EXTRACT, ARGININE HYDROCHLORIDE, ORNITHINE HYDROCHLORIDE AND CITRULLINE IN PATIENTS WITH LIVER DISEASES].
    DRAGO U; FINOTTO E; ONGARO G
    Minerva Med; 1964 Apr; 55():1187-91. PubMed ID: 14152730
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.